Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Bo Ding, Stephanie Chen, Aayushi Agrawal, Divyansh Srivastava, Jaime Solorzano, Bill Cook, Alberto Papi, Helen K Reddel
European Respiratory Journal 2021 58: OA4214; DOI: 10.1183/13993003.congress-2021.OA4214
Bo Ding
1BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden
Stephanie Chen
2BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, United States of America
Aayushi Agrawal
3ZS Associates, New Delhi, India
Divyansh Srivastava
4ZS Associates, Pune, India
Jaime Solorzano
5BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
Bill Cook
2BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, United States of America
Alberto Papi
6Respiratory Medicine Unit, Department of Translational Medicine, Università di Ferrara, Ferrara, Italy
Helen K Reddel
7Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia
Vol 58 Issue suppl 65
Table of Contents
Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Bo Ding, Stephanie Chen, Aayushi Agrawal, Divyansh Srivastava, Jaime Solorzano, Bill Cook, Alberto Papi, Helen K Reddel
European Respiratory Journal Sep 2021, 58 (suppl 65) OA4214; DOI: 10.1183/13993003.congress-2021.OA4214